SPONSOR
Grit Biotechnology
Total Trials
3
Recruiting
3
Phases
EARLY_Phase 1
Conditions studied: B-cell Acute Lymphoblastic Leukemia (B-ALL)Chronic Lymphocytic Leukemia (CLL)B-cell Non-Hodgkin's Lymphoma (B-NHL)Autoimmune Hemolytic Anemia (AIHA)Hematological Malignancy (Leukemia- Lymphoma)AdultNon-small Cell Lung Cancer
NCT07205315 EARLY_Phase 1
Recruiting
A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia
B-cell Acute Lymphoblastic Leukemia (B-ALL)
NCT07131254 EARLY_Phase 1
Recruiting
A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors
Hematological Malignancy (Leukemia- Lymphoma)
NCT06235242
Recruiting
GT201 Injection in Combination with Teraplizumab Injection for Treatment of Patients with Non-small Cell Lung Cancer
Adult